4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-21-020437
Director acquired 11,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2021-06-08 | Grant or award | +11,000 | 111,818 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2021-06-08 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…